Nguyen Thi Thu Hong

Nguyen Thi Thu Hong

Auto-generated profile, based on publicly available information

Nguyen Thi Thu Hong

Oxford University Clinical Research Unit , Ho Chi Minh City

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2026 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
LNLam Anh Nguyet
Lam Anh Nguyet
NANguyen To Anh
Nguyen To Anh
DQDu Tuan Quy
Du Tuan Quy
NHNguyen Thi Thu Hong
Nguyen Thi Thu Hong
NMNgo Ngoc Quang Minh
Ngo Ngoc Quang Minh
LTLe Van Tan
Le Van Tan
We report on the virological and epidemiological features of a severe hand foot and mouth disease outbreak in Vietnam in 2023. Enterovirus A71 (EV-A71) subgenogroup B5, first emerging around November 2022, and imported into Vietnam through a single introduction, was the primary cause. Convalescent plasma collected from patients infected with subgenogroups B5 in 2014 and 2023 could neutralize both contemporary viruses with comparable titers, suggesting no evidence of immune evasion. However, at one and six months before the start of the outbreak, only 6.7% of 0– < 3 year-old children in Ho Chi Minh City, an epicenter of the outbreak, had neutralizing antibodies against EV-A71. Seroprevalence increased as the outbreak progressed, coinciding with a drop in EV-A71 infected patients residing in Ho Chi Minh City, suggesting that serosurveillance could be a useful tool to assess the risk of pathogen emergence. Our collective findings have provided novel insights into the epidemiological factors driving EV-A71 emergence, and therefore would inform outbreak preparedness and response, and in particular the development of serosurveillance-based approach to assess the risk of pathogen emergence. EV-A71 infection represents an ongoing public health threat, currently affecting countries in the Asia-Pacific region, but with a high potential to become a global problem, and therefore should be closely monitored.

6 January 2026 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
NHNguyen Thi Thu Hong
Nguyen Thi Thu Hong
BKBarbara Kronsteiner
Barbara Kronsteiner
TTTran Tan Thanh
Tran Tan Thanh
MZMartha Zewdie
Martha Zewdie
MAMOHAMMAD ALI
MOHAMMAD ALI
LTLe Van Tan
Le Van Tan
Widespread SARS-CoV-2 infection and vaccination have reshaped global immunity to coronaviruses. Whether this immunity extends to animal sarbecoviruses with spillover potential remains unknown. We assessed cross-reactive memory T-cell responses to spike proteins from five relevant human angiotensin-converting enzyme 2 (hACE2)-dependent sarbecoviruses and MERS-CoV in healthcare workers in the UK and Vietnam. Limited SARS-CoV-2-specific or cross-reactive responses were seen in pre-pandemic samples. However, in samples collected from vaccinated donors at 3–24 months after booster vaccination, cross-reactive T-cell responses across the hACE2-dependent sarbecoviruses were detected. There was a strong correlation between the magnitude of responses and the level of viral sequence identity. This relationship was reproduced across cohorts in the UK and Vietnam. These findings indicate that post-pandemic populations possess measurable cellular immunity to genetically related sarbecoviruses and suggest that the degree of T-cell cross-recognition can be predicted from the spike protein sequence conservation. Such data provide an immunological framework for assessing vulnerability to future sarbecovirus spillover.

28 April 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
NPNguyen Nguyen The Phung
Nguyen Nguyen The Phung
NHNguyen Thanh Hung
Nguyen Thanh Hung
NMNgo Ngoc Quang Minh
Ngo Ngoc Quang Minh
NHNguyen Thi Thu Hong
Nguyen Thi Thu Hong
NHNguyen Thi Thanh Huong
Nguyen Thi Thanh Huong
WYWee Chee Yap
Wee Chee Yap
Novel clade 2.3.2.1e A(H5N1) virus was detected in cerebrospinal fluid but not in respiratory, rectal swab, or blood samples of an 8-year-old boy presenting with meningoencephalitis without respiratory symptoms. Cerebrospinal fluid A(H5N1) hemagglutinin–specific antibody levels were higher than those of sera. Clinicians should be aware of emerging clade 2.3.2.1e A(H5N1)–associated meningoencephalitis.